Creative Planning Novo Nordisk A S Transaction History

Creative Planning

  • $103 Billion
  • Q4 2024

A detailed history of Creative Planning transactions in Novo Nordisk A S stock. As of the latest transaction made, Creative Planning holds 308,622 shares of NVO stock, worth $27.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
308,622
Previous 294,799 4.69%
Holding current value
$27.5 Million
Previous $35.1 Million 24.37%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$85.0 - $120.04 $1.17 Million - $1.66 Million
13,823 Added 4.69%
308,622 $26.5 Million
Q3 2024

Oct 11, 2024
BUY
$119.07 - $145.42 $1.57 Million - $1.92 Million
13,203 Added 4.69%
294,799 $35.1 Million
Q2 2024

Aug 15, 2024
BUY
$122.71 - $146.91 $2.8 Million - $3.36 Million
22,848 Added 8.83%
281,596 $40.2 Million
Q1 2024

May 10, 2024
BUY
$102.11 - $135.92 $4.23 Million - $5.63 Million
41,425 Added 19.06%
258,748 $33.2 Million
Q4 2023

Feb 14, 2024
BUY
$87.78 - $105.45 $2.44 Million - $2.93 Million
27,776 Added 14.65%
217,323 $22.5 Million
Q3 2023

Nov 16, 2023
BUY
$90.94 - $199.54 $9.25 Million - $20.3 Million
101,667 Added 115.69%
189,547 $17.2 Million
Q2 2023

Jul 21, 2023
BUY
$155.98 - $172.65 $1.45 Million - $1.61 Million
9,310 Added 11.85%
87,880 $14.2 Million
Q1 2023

May 15, 2023
BUY
$132.34 - $159.14 $490,452 - $589,772
3,706 Added 4.95%
78,570 $12.5 Million
Q4 2022

Feb 10, 2023
BUY
$102.55 - $135.33 $265,296 - $350,098
2,587 Added 3.58%
74,864 $10.1 Million
Q3 2022

Nov 03, 2022
BUY
$95.28 - $116.93 $522,610 - $641,361
5,485 Added 8.21%
72,277 $7.2 Million
Q2 2022

Aug 15, 2022
BUY
$103.24 - $121.81 $1.01 Million - $1.2 Million
9,813 Added 17.22%
66,792 $7.44 Million
Q1 2022

May 16, 2022
BUY
$93.1 - $112.54 $117,212 - $141,687
1,259 Added 2.26%
56,979 $6.33 Million
Q4 2021

Feb 11, 2022
SELL
$95.88 - $117.08 $319,759 - $390,461
-3,335 Reduced 5.65%
55,720 $6.24 Million
Q3 2021

Nov 10, 2021
SELL
$84.42 - $106.62 $493,772 - $623,620
-5,849 Reduced 9.01%
59,055 $5.67 Million
Q2 2021

Aug 04, 2021
SELL
$67.66 - $84.76 $1.81 Million - $2.27 Million
-26,739 Reduced 29.18%
64,904 $5.44 Million
Q1 2021

Apr 30, 2021
SELL
$67.06 - $75.82 $1.47 Million - $1.67 Million
-21,992 Reduced 19.35%
91,643 $6.18 Million
Q4 2020

Jan 29, 2021
BUY
$63.89 - $73.8 $5.47 Million - $6.32 Million
85,693 Added 306.68%
113,635 $7.94 Million
Q3 2020

Nov 05, 2020
BUY
$63.69 - $70.22 $303,992 - $335,160
4,773 Added 20.6%
27,942 $1.94 Million
Q2 2020

Jul 23, 2020
SELL
$58.54 - $67.94 $494,077 - $573,413
-8,440 Reduced 26.7%
23,169 $1.52 Million
Q1 2020

May 05, 2020
SELL
$49.46 - $64.78 $5,044 - $6,607
-102 Reduced 0.32%
31,609 $1.9 Million
Q4 2019

Jan 30, 2020
SELL
$49.86 - $58.26 $157,557 - $184,101
-3,160 Reduced 9.06%
31,711 $1.84 Million
Q3 2019

Nov 01, 2019
SELL
$47.54 - $53.43 $24,150 - $27,142
-508 Reduced 1.44%
34,871 $1.8 Million
Q2 2019

Jul 26, 2019
BUY
$46.79 - $52.47 $408,944 - $458,587
8,740 Added 32.81%
35,379 $1.81 Million
Q1 2019

Apr 24, 2019
SELL
$46.36 - $52.63 $456,136 - $517,826
-9,839 Reduced 26.97%
26,639 $1.39 Million
Q4 2018

Feb 01, 2019
SELL
$41.54 - $47.25 $153,490 - $174,588
-3,695 Reduced 9.2%
36,478 $1.68 Million
Q3 2018

Oct 25, 2018
SELL
$46.76 - $51.24 $42,411 - $46,474
-907 Reduced 2.21%
40,173 $1.89 Million
Q2 2018

Jul 20, 2018
BUY
$44.29 - $50.42 $108,599 - $123,629
2,452 Added 6.35%
41,080 $1.9 Million
Q1 2018

Apr 18, 2018
SELL
$48.49 - $58.14 $327,355 - $392,503
-6,751 Reduced 14.88%
38,628 $1.9 Million
Q4 2017

Jan 17, 2018
BUY
$47.53 - $53.73 $222,773 - $251,832
4,687 Added 11.52%
45,379 $2.44 Million
Q3 2017

Oct 17, 2017
BUY
$41.15 - $49.22 $1.67 Million - $2 Million
40,692
40,692 $1.96 Million

Others Institutions Holding NVO

# of Institutions
1,882
Shares Held
336M
Call Options Held
11.9M
Put Options Held
10.6M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $201B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email